Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Thomas

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Oncology|June 26, 2004
Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology groupRobert C Shepard, Donna E Levy, Jordan D Berlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2007
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803Leonard B Saltz, Donna Niedzwiecki, Donna Hollis, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2008
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumorsWilliam Schelman, Sherry Morgan-Meadows, Howard Bailey, et al.
American Journal of Clinical Oncology|June 11, 2003
Gemcitabine, Paclitaxel, and piritrexim: a phase I studyGlenn Liu, Howard H Bailey, Rhoda Z Arzoomanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2007
Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumorsHoward H Bailey, Dona B Alberti, James P Thomas, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2008
A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancerNoelle K LoConte, James P Thomas, Dona Alberti, et al.
Clinical Colorectal Cancer|July 21, 2010
A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancerSam J Lubner, Noelle K Loconte, Kyle D Holen, et al.
The Oncologist|February 27, 2014
Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?Kathleen K Christians, Susan Tsai, Anna Mahmoud, et al.
Oncology|August 25, 2005
A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinomaSherry Morgan-Meadows, Daniel Mulkerin, Jordan D Berlin, et al.
Plos One|October 9, 2015
Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-AnalysisAnthony J Zacharias, Thejus T Jayakrishnan, Rahul Rajeev, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Oncology|June 26, 2004
Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology groupRobert C Shepard, Donna E Levy, Jordan D Berlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2007
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803Leonard B Saltz, Donna Niedzwiecki, Donna Hollis, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2008
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumorsWilliam Schelman, Sherry Morgan-Meadows, Howard Bailey, et al.
American Journal of Clinical Oncology|June 11, 2003
Gemcitabine, Paclitaxel, and piritrexim: a phase I studyGlenn Liu, Howard H Bailey, Rhoda Z Arzoomanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2007
Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumorsHoward H Bailey, Dona B Alberti, James P Thomas, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2008
A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancerNoelle K LoConte, James P Thomas, Dona Alberti, et al.
Clinical Colorectal Cancer|July 21, 2010
A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancerSam J Lubner, Noelle K Loconte, Kyle D Holen, et al.
The Oncologist|February 27, 2014
Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?Kathleen K Christians, Susan Tsai, Anna Mahmoud, et al.
Oncology|August 25, 2005
A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinomaSherry Morgan-Meadows, Daniel Mulkerin, Jordan D Berlin, et al.
Plos One|October 9, 2015
Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-AnalysisAnthony J Zacharias, Thejus T Jayakrishnan, Rahul Rajeev, et al.
Pageof 5